SLN - Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
2024-06-24 09:22:45 ET
More on Silence Therapeutics
- Silence Therapeutics: PV Data For Consideration After ASCVD Treatment Results
- Silence Therapeutics achieves $2M research milestone payment from Hansoh collaboration
- Silence releases promising phase 2 results of zerlasiran to lower lipoprotein
- Seeking Alpha’s Quant Rating on Silence Therapeutics
- Historical earnings data for Silence Therapeutics